
Regulation: Cannabis – USA
October 2026: Federal Cannabis Rescheduling Process Temporarily Paused at the DEA Amid New Review The long-awaited federal administrative process to reclassify cannabis from Schedule I

October 2026: Federal Cannabis Rescheduling Process Temporarily Paused at the DEA Amid New Review The long-awaited federal administrative process to reclassify cannabis from Schedule I

October 2026: Connecticut’s Cannabis Market Sees Falling Prices and Cooling Sales in 2026 Connecticut’s legal cannabis market is experiencing a notable shift as retail prices

August 2026: Canadian Legal Cannabis Retail Reaches Record CA$517.8 Million in June Canada’s legal adult-use cannabis sector has reached a landmark milestone. Newly released retail

The Evolving Economics and Demographics of American Cannabis: A Market Analysis From a niche counterculture product to a multi-billion-dollar commercial engine, the American cannabis landscape

[For the developments in the USA and Canada, refer to Cannabis: USA and Cannabis: Canada] May 2026: Global Cannabis Prices Fall Sharply as Oversupply Intensifies

January 2026: Cannabis Sales Tax Hike Takes Effect In Maine Sales taxes on the purchase of adult-use cannabis products increased from 10% to 14% in

U.S. Cannabis Industry at a Crossroads: Policy Shifts, Market Pressures and Strategic Trends Heading Into 2026 The U.S. cannabis industry experienced a year of extraordinary

June 2025: Cannabis vape products provider Papa Medical sets terms for $5 million IPO Papa Medical, which sells branded cannabis vape devices primarily in North

[For the regulatory developments in the USA, refer to Regulation: Cannabis – USA] June 2025: Thailand moves to recriminalize cannabis Thai Government moves to recriminalize

Cannabis contains a lot of compounds, and many of them are cannabinoids – active chemicals that interact with our body’s endocannabinoid system. Below is a